secwatch / observer

8-K filed May 21, 2026, 4:43 PM ET CIK 0001948056

other material confidence high sentiment neutral materiality 0.60

KKR Infrastructure Conglomerate reports April 30, 2026 Transactional NAV per share range of $30.30-$35.74

KKR Infrastructure Conglomerate LLC

Total Transactional Net Asset Value of $7.65B across 252.1M shares outstanding.
Class U NAV $30.30, Class R $30.35, Class D $30.31, Class I/S $30.33, Class F $32.07, Class G/H $35.74.
GAAP Net Asset Value of $7.40B reconciled to Transactional NAV via $218M accrued servicing fees, $17.2M deferred tax liabilities, and $14.2M unamortized acquisition costs.
Valuation inputs: 81.8% weight to discounted cash flow, WACC 11.9% (range 6.3%-25.6%), terminal EBITDA multiple 14.0x.
0.25% decrease in WACC would increase asset values by +2.22%; 0.25% increase would decrease by -2.10%.

item 8.01 item 9.01

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001948056-26-000039
form_type: 8-K
ticker: null
cik: 0001948056
company_name: KKR Infrastructure Conglomerate LLC
filed_at: 2026-05-21T20:43:50+00:00
discovered_at: 2026-05-21T20:45:00.338080+00:00
generated_at: 2026-05-21T20:45:39.009042+00:00
sec_items: ["8.01", "9.01"]
event_type: other_material
sentiment: neutral
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0001948056-26-000039
json_url: https://secwatch.observer/filing/0001948056-26-000039.json
markdown_url: https://secwatch.observer/filing/0001948056-26-000039.md
text_url: https://secwatch.observer/filing/0001948056-26-000039.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/1948056/000194805626000039/0001948056-26-000039-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/1948056/000194805626000039/kkr-20260521.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Comparable filings

SYRE

Spyre Therapeutics expands SPY003 license field beyond IBD with dosing restrictions until 2028-2030

Spyre Therapeutics, Inc. June 1, 2026, 4:01 PM ET other_material Items 8.01, 9.01

same SEC item: 8.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

ORKA

Oruka Therapeutics expands ORKA-001 license to include IBD; clinical dosing restrictions until 2028-2030

Oruka Therapeutics, Inc. June 1, 2026, 4:01 PM ET other_material Items 8.01, 9.01

same SEC item: 8.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

Via Renewables to redeem all 1,884,935 shares of its 8.75% Series A Preferred at $25.00 per share plus dividends

Via Renewables, Inc. June 1, 2026, 3:06 PM ET other_material Items 8.01, 9.01

same SEC item: 8.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

BUKS

CEO Christopher Reedy discloses ongoing cancer treatment; remains in role

BUTLER NATIONAL CORP June 1, 2026, 12:41 PM ET other_material Items 8.01, 9.01

same SEC item: 8.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

CPSH

CPS Technologies closes $9.6M registered direct offering of 1.2M shares at $8.00/share

CPS TECHNOLOGIES CORP/DE/ June 1, 2026, 9:35 AM ET other_material Items 1.01, 5.03, 8.01, 9.01

same SEC item: 8.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

DBX

Dropbox secures $400M revolving credit facility, authorizes $900M share repurchase program

DROPBOX, INC. June 1, 2026, 9:06 AM ET other_material Items 1.01, 2.03, 7.01, 8.01, 9.01

same SEC item: 8.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

ONCY

Oncolytics reports positive initial preclinical data for pelareorep + RAS inhibitors; further studies planned

ONCOLYTICS BIOTECH INC June 1, 2026, 9:06 AM ET other_material Items 8.01, 9.01

same SEC item: 8.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

CLIR

ClearSign Technologies prices 777,780-share public offering at $4.33/share for ~$3.37M gross proceeds

ClearSign Technologies Corp June 1, 2026, 8:30 AM ET other_material Items 1.01, 8.01, 9.01

same SEC item: 8.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

Source: SEC EDGAR

accession 0001948056-26-000039

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.